Clinical Trial Update: Effectiveness of Dapagliflozin for Weight Loss [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports the effectiveness of dapagliflozin for weight loss in adults with prediabetes, obesity, morbid obesity, and type 2 diabetes m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Obesity
• Prediabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: Centro Medico Nacional Siglo XXI IMSS | Conditions: PreDiabetes, Obesity, Morbid | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2025-10-15